TY  - JOUR
T1  - OFf-label atypical antipsychotics
AU  - Kuehn BM
Y1  - 2012/09/26
N1  - 10.1001/2012.jama.12018
JO  - JAMA
SP  - 1198
EP  - 1198
VL  - 308
IS  - 12
N2  - 
Increasing off-label use of atypical antipsychotics and requests for information about such use led the AHRQ to review the data to date (http://tinyurl.com/9am42ag). Medications of this class of drugs are approved by the US Food and Drug Administration for the treatment of schizophrenia and bipolar disorder, and a few have also been approved for major depression and autism-related aggression. Yet they are often prescribed for other indications.

SN  - 0098-7484
M3  - doi: 10.1001/2012.jama.12018
UR  - http://dx.doi.org/10.1001/2012.jama.12018
ER  -